Alerts

Human albumin: Clinical advice on ethylene glycol

The Therapeutic Goods Administration (TGA) has taken steps today to quarantine CSL Human Albumin solutions from further use while an assessment is undertaken of the safety of these products.

We are updating safety information for statins due to potential risks like memory loss and increased blood sugar levels. Consult your doctor if you have concerns.

Poly Implant Prothèse (PIP) update

TGA has increased the number of samples of PIP breast implants tested for shell integrity

Information on the management of issues related to the recall of PIP silicone gel breast implants

Information on the management of issues related to the recall of PIP silicone gel breast implants

Counterfeit Avastin injections found in the USA do not have the active ingredient. We've reminded health professionals that importing or supplying counterfeit medicines in Australia is illegal.

Poly Implant Prothèse (PIP) update

PIP breast implants were available in Australia between 1998 and April 2010. In April 2010 non-implanted PIP breast implants were recalled from the Australian marketplace following reports of increased risk of rupture with PIP breast implants as a result of use by the manufacturer of non-approved silicone gel.

The TGA advises that while PIP breast implants were recalled due to the use of unauthorised silicone, current evidence does not support routine removal in patients without symptoms, and individuals are encouraged to seek medical advice if concerned.

At the time of writing, the TGA has been advised that approximately 9,054 PIP breast implants have been implanted by surgeons between 2002 and 2010. In April 2010 non-implanted PIP breast implants were recalled from the Australian marketplace.

Updated recommendations for Pneumovax 23 revaccination due to high rates of local reactions after repeat doses.

We are updating safety information for Simvastatin due to new contraindications, precautions, and dosage recommendations. Consult your doctor if you have concerns.

The recall is being conducted because a routine sterility test on the Trident Catheter Valve in a particular set of lots has failed.

Concerns over the sterility of the affected lots were raised following the failure of the sterility testing conducted by the manufacturer.